Clinical and Translational Science
© Wiley Periodicals, Inc.
Edited By: Arthur M. Feldman, MD, PhD
Impact Factor: 2.11
ISI Journal Citation Reports © Ranking: 2013: 65/122 (Medicine Research & Experimental)
Online ISSN: 1752-8062
Clinical and Translational Science is now indexed in MEDLINE and ISI! CTS has been awarded its first Impact Factor, 1.132, in the Medicine, Research, and Experimental category.
Free online access through 2011. View content online.
Following are the top five most-accessed articles in 2009 published in Clinical and Translational Science:
CTS: A New Discipline to Catalyze the Transfer of Information
Arthur M. Feldman, MD, PhD
Vol. 1, No. 1, May 2008
Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans
Vishal S. Vaidya, Sushrut S. Waikar, Michael A. Ferguson, Fitz B. Collings, Kelsey Sunderland, Costas Gioules, Gary Bradwin, Roland Matsouaka, Rebecca A. Betensky, Gary C. Curhan, and Joseph V. Bonventre
Vol. 1, No. 3, December 2008
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Allison B. Goldfine, Robert Silver, Waleed Aldhahi, Dongsheng Cai, Elizabeth Tatro, Jongsoon Lee, and Steven E. Shoelson
Vol. 1, No. 1, May 2008
ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells
Jaime Lindsay, Ph.D., Xuanmao Jiao, Ph.D., Toshiyuki Sakamaki, Ph.D., Mathew C. Casimiro, Ph.D., Lawrence A. Shirley, M.D., Thai H. Tran, Ph.D., Xiaoming Ju, M.D., Manran Liu, Ph.D., Zhiping Li, M.D., Ph.D., Chenguang Wang, Ph.D., Sanjay Katiyar, Ph.D., Mahadev Rao, Ph.D., Kathleen G. Allen, M.D., Robert I. Glazer, Ph.D., Changhui Ge, Ph.D., Pamela Stanley, Ph.D., Michael P. Lisanti, M.D., Ph.D., Hallgeir Rui, M.D., Ph.D., and Richard G. Pestell, M.D., Ph.D.
Vol. 1, No. 2, September 2008
Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
Risto Kerkela, Kathleen C. Woulfe, Jean-Bernard Durand, Ronald Vagnozzi, David Kramer, Tammy F. Chu, Cara Beahm, Ming Hui Chen, and Thomas Force
Vol. 2, No. 1, February 2009
STUDY FINDS ANTI-INFLAMMATORY MEDICATION MAY TREAT TYPE 2 DIABETES: Builds on earlier study that showed inexpensive drug may also prevent the disease
BOSTON - May 22, 2008 - Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.
The paper, which appears in the May 2008 issue of the journal Clinical and Translational Science (CTS), reports on three proof-of-concept studies that demonstrate that salsalate, which has been used for decades to treat arthritis, may benefit patients with type 2 diabetes by lowering blood sugar and reducing inflammation.